Stelo Glucose Sensor: How Dexcom’s OTC CGM Works

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • The Stelo glucose sensor is Dexcom's first over-the-counter continuous glucose monitor, FDA cleared in March 2024 for adults age 18 and up who are not on insulin.
  • Each sensor lasts 15 days and is worn on the back of the upper arm; readings stream to the Stelo app every 15 minutes.
  • Stelo does not require a prescription and is sold directly from Dexcom and select pharmacies for around $89-$99 per sensor or about $159 per 2-pack.
  • Stelo uses the same sensor technology as Dexcom G7 but is tuned for non-insulin users; it has no urgent low alarm and is not approved for insulin dosing.
  • Stelo is best for prediabetes, type 2 diabetes managed with lifestyle or oral medications, weight management, and general metabolic awareness.

The Stelo glucose sensor is the first over-the-counter continuous glucose monitor sold in the United States, manufactured by Dexcom and FDA cleared in March 2024. It is designed for adults age 18 and older who do not use insulin, including people with prediabetes, type 2 diabetes managed without insulin, and anyone interested in metabolic health. Each sensor lasts 15 days, requires no prescription, and streams readings to the Stelo smartphone app every 15 minutes.

What Makes Stelo Different

Until 2024 every CGM in the US required a prescription. Stelo broke that pattern as the first FDA-cleared OTC glucose biosensor. Abbott followed with Lingo and Libre Rio, but Stelo was first to market and remains the most widely available OTC option. According to the FDA’s March 2024 clearance announcement, Stelo is intended for adults who are not at risk for severe hypoglycemia and who want to learn how lifestyle factors affect blood glucose.

How Stelo Works

The Stelo sensor is a single-piece disc, similar in size to a US quarter, that you apply to the back of your upper arm with a one-handed applicator. A thin filament about 4 mm long inserts under the skin and sits in the interstitial fluid between cells. The filament is coated with the enzyme glucose oxidase, which reacts with glucose to produce a small electrical current. The current is converted to a glucose value and sent over Bluetooth Low Energy to the Stelo app on your phone every 15 minutes.

Stelo Specifications

Spec Stelo
Wear time 15 days
Warm-up period 30 minutes
Reading frequency Every 15 minutes (app)
Calibration Factory calibrated; no fingersticks
Water resistance 8 feet for 24 hours
Reported MARD ~10 percent
App platforms iOS and Android
Approved age 18 and older, non-insulin users

Stelo vs Dexcom G7 vs FreeStyle Libre 3

Feature Stelo (OTC) Dexcom G7 (Rx) FreeStyle Libre 3 (Rx)
Prescription needed No Yes Yes
Wear time 15 days 10 days + 12 hr grace 14 days
Reading frequency 15 min 5 min 1 min
Insulin dosing approved No Yes Yes
Urgent low alarm No Yes Yes
Typical cost (cash) $89-$99/sensor $89-$120/sensor $75-$140/sensor

Who Should Use Stelo

  • People with prediabetes who want to see how meals affect post-meal glucose and trend toward a healthier baseline
  • Type 2 diabetes patients on metformin or diet alone who do not need urgent-low alerts
  • People in weight-loss programs, particularly those on GLP-1 agonists like semaglutide or tirzepatide, who want to see metabolic changes
  • Athletes and biohackers exploring meal timing, fasting, and exercise
  • Caregivers of family members with prediabetes who want a low-cost way to track patterns

Who Should Not Use Stelo

  • Anyone using insulin (basal or bolus) – Stelo is not approved for insulin dosing
  • People with a history of severe hypoglycemia or hypoglycemia unawareness
  • Children under 18
  • Pregnant patients – use a prescription CGM that has been studied in pregnancy
  • People with diabetes managed with sulfonylureas, glinides, or other insulin secretagogues at risk of lows

Stelo App Features

The Stelo app shows your current glucose, a 24-hour graph, time in range, and a “Spike” log that highlights post-meal peaks. Unlike Dexcom G7’s Clarity app, Stelo does not have urgent-low alarms but does send a high-glucose notification if values exceed a user-set threshold (default 250 mg/dL). The app integrates with Apple Health and Google Fit, and many users pair it with food and activity logs in apps like MyFitnessPal or Fitbit.

Cost and How to Buy

Stelo is sold direct from Dexcom at stelo.com and through select retail partners. Pricing as of 2025:

  • Single sensor (15 days): about $89
  • 2-pack (30 days): about $159
  • Subscription (delivered every 30 days): about $89 per month

Stelo is not currently covered by Medicare or most commercial insurance plans because it is an OTC consumer product. HSA and FSA funds can typically be used for purchases.

How to Apply a Stelo Sensor

  1. Choose a clean spot on the back of either upper arm.
  2. Wash with soap, dry, then wipe with an alcohol pad and let fully air dry.
  3. Twist off the cap on the applicator and align the white circle on your skin.
  4. Press firmly until you hear or feel the click; the sensor is now applied.
  5. Open the Stelo app, scan the sensor with your phone, and wait 30 minutes for warm-up.

Where Stelo Fits in Prediabetes Care

For people in the prediabetes range, Stelo provides immediate visibility into how oatmeal vs eggs, a 20-minute walk after dinner, or a poor night of sleep affects glucose. That feedback can accelerate behavior change. According to the American Diabetes Association, CGM use in prediabetes is an emerging area of research, with early studies showing improved time in range when paired with coaching. For more on detection and treatment, see the detection of prediabetes guide and the A1C levels hub.

The Bottom Line

The Stelo glucose sensor is the first OTC CGM in the US, designed for non-insulin adults who want continuous glucose insights without a prescription. It uses Dexcom G7 hardware tuned for non-insulin users, lasts 15 days per sensor, costs about $89-$99, and pairs with the Stelo app for trend tracking. It is a strong option for prediabetes, type 2 diabetes managed without insulin, and metabolic-health curiosity, but not appropriate for insulin users.

Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider with any questions about a medical condition or medication.

Frequently Asked Questions

Who is the Stelo glucose sensor for?

Stelo is approved for adults 18 and older who do not use insulin. That includes people with prediabetes, type 2 diabetes managed with diet or oral medication, those interested in metabolic health, and people exploring how meals, exercise, sleep, and stress affect their glucose. People who use insulin should use a prescription CGM like Dexcom G7 or Libre 3 instead because Stelo lacks urgent-low alarms and insulin-dosing approval.

How accurate is the Stelo sensor compared to Dexcom G7?

Stelo uses the same hardware platform as Dexcom G7 but is calibrated for non-insulin users. The reported mean absolute relative difference (MARD) for Stelo is approximately 10 percent, compared to about 8 percent for G7. Both meet the FDA accuracy threshold for their intended use. Stelo updates readings every 15 minutes; G7 streams every 5 minutes. Either is suitable for trend monitoring in non-insulin users.

How much does Stelo cost without insurance?

Stelo is sold direct-to-consumer from Dexcom at around $89 for a single 15-day sensor, $159 for a 2-pack (30 days), and discounted subscription pricing of about $89 per month for ongoing delivery. It is not currently covered by Medicare or most commercial insurance because it is an OTC consumer product. Some HSA and FSA accounts may reimburse Stelo as an eligible medical expense.

Sources

  1. U.S. Food and Drug Administration. FDA Clears First Over-the-Counter Continuous Glucose Monitor (Dexcom Stelo). March 2024. https://www.fda.gov/news-events/press-announcements
  2. Dexcom Inc. Stelo Glucose Biosensor System User Guide and Press Release. https://www.stelo.com
  3. American Diabetes Association. Standards of Care 2024 Diabetes Technology. https://diabetesjournals.org/care